New England Capital Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.3K Hold
34
0.01% 149
2026
Q1
$31.6K Hold
34
0.01% 156
2025
Q4
$36.9K Buy
34
+20
+143% +$19.1K 0.01% 153
2025
Q3
$10.9K Hold
14
﹤0.01% 249
2025
Q2
$11.1K Hold
14
0.01% 238
2025
Q1
$11.8K Hold
14
0.01% 217
2024
Q4
$11K Hold
14
0.01% 224
2024
Q3
$12.6K Hold
14
0.01% 213
2024
Q2
$12.8K Hold
14
0.01% 212
2024
Q1
$11K Hold
14
0.01% 219
2023
Q4
$8.24K Hold
14
0.01% 243
2023
Q3
$7.58K Sell
14
-101
-88% -$52K 0.01% 244
2023
Q2
$53.7K Hold
115
0.04% 106
2023
Q1
$39.3K Buy
115
+15
+15% +$5.06K 0.03% 136
2022
Q4
$34.8K Buy
+100
New +$35.5K 0.02% 144

Other funds holding LLY

New England Capital Financial Advisors's LLY Position: Q2 2026 in Review

New England Capital Financial Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 34 shares worth $41.3K. The position accounts for 0.01% of the portfolio, ranked #149.

New England Capital Financial Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $53.7K in Q2 2023. 1,644 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New England Capital Financial Advisors held 34 shares of Eli Lilly worth $41.3K as of Q2 2026.
  • New England Capital Financial Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #149 holding.
  • New England Capital Financial Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Eli Lilly position peaked at $53.7K in Q2 2023.
  • 1,644 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.